{"id":"https://openalex.org/W1999742425","doi":"https://doi.org/10.1161/01.cir.104.2.197","title":"In Vivo Downregulation of T Helper Cell 1 Immune Responses Reduces Atherogenesis in Apolipoprotein E-Knockout Mice","display_name":"In Vivo Downregulation of T Helper Cell 1 Immune Responses Reduces Atherogenesis in Apolipoprotein E-Knockout Mice","publication_year":2001,"publication_date":"2001-07-10","ids":{"openalex":"https://openalex.org/W1999742425","doi":"https://doi.org/10.1161/01.cir.104.2.197","mag":"1999742425","pmid":"https://pubmed.ncbi.nlm.nih.gov/11447086"},"language":"en","primary_location":{"id":"doi:10.1161/01.cir.104.2.197","doi":"https://doi.org/10.1161/01.cir.104.2.197","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.cir.104.2.197","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1999742425"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082430196","display_name":"Elisabeth Laurat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210166329","display_name":"H\u00f4pital Broussais","ror":"https://ror.org/05h8pvh61","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166329"]}],"countries":["FR","SE"],"is_corresponding":false,"raw_author_name":"E. Laurat","raw_affiliation_strings":["From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I28166907","https://openalex.org/I4210166329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038885109","display_name":"Bruno Poirier","orcid":"https://orcid.org/0000-0001-6748-1732","observed_orcids":["https://orcid.org/0000-0001-6748-1732"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210166329","display_name":"H\u00f4pital Broussais","ror":"https://ror.org/05h8pvh61","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166329"]}],"countries":["FR","SE"],"is_corresponding":false,"raw_author_name":"B. Poirier","raw_affiliation_strings":["From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I28166907","https://openalex.org/I4210166329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071870114","display_name":"Emmanuel Tupin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210166329","display_name":"H\u00f4pital Broussais","ror":"https://ror.org/05h8pvh61","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166329"]}],"countries":["FR","SE"],"is_corresponding":false,"raw_author_name":"E. Tupin","raw_affiliation_strings":["From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I28166907","https://openalex.org/I4210166329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077562273","display_name":"Giuseppina Caligiuri","orcid":"https://orcid.org/0000-0003-4973-2205","observed_orcids":["https://orcid.org/0000-0003-4973-2205"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210166329","display_name":"H\u00f4pital Broussais","ror":"https://ror.org/05h8pvh61","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166329"]}],"countries":["FR","SE"],"is_corresponding":false,"raw_author_name":"G. Caligiuri","raw_affiliation_strings":["From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I28166907","https://openalex.org/I4210166329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004855576","display_name":"G\u00f6ran K. Hansson","orcid":"https://orcid.org/0000-0003-4148-5190","observed_orcids":["https://orcid.org/0000-0003-4148-5190"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210166329","display_name":"H\u00f4pital Broussais","ror":"https://ror.org/05h8pvh61","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166329"]}],"countries":["FR","SE"],"is_corresponding":false,"raw_author_name":"G.K. Hansson","raw_affiliation_strings":["From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I28166907","https://openalex.org/I4210166329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089507696","display_name":"Jean Bariety","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210166329","display_name":"H\u00f4pital Broussais","ror":"https://ror.org/05h8pvh61","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166329"]}],"countries":["FR","SE"],"is_corresponding":false,"raw_author_name":"J. Barie\u0301ty","raw_affiliation_strings":["From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I28166907","https://openalex.org/I4210166329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036984977","display_name":"Antonino Nicoletti","orcid":"https://orcid.org/0000-0002-2623-0897","observed_orcids":["https://orcid.org/0000-0002-2623-0897"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210166329","display_name":"H\u00f4pital Broussais","ror":"https://ror.org/05h8pvh61","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166329"]}],"countries":["FR","SE"],"is_corresponding":true,"raw_author_name":"A. Nicoletti","raw_affiliation_strings":["From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From INSERM U430, Ho\u0302pital Broussais (E.L., B.P., E.T., J.B., A.N.), and INSERM U460, Ho\u0302pital Bichat (G.C.), Paris, France; and the Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (G.K.H.). The first 2 authors contributed equally to this work","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I28166907","https://openalex.org/I4210166329"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5036984977"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I28166907","https://openalex.org/I4210166329"],"apc_list":null,"apc_paid":null,"fwci":5.0193,"has_fulltext":false,"cited_by_count":285,"citation_normalized_percentile":{"value":0.96186041,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"104","issue":"2","first_page":"197","last_page":"202"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.878000020980835},{"id":"https://openalex.org/keywords/th1-response","display_name":"Th1 response","score":0.8640000224113464},{"id":"https://openalex.org/keywords/pentoxifylline","display_name":"pentoxifylline","score":0.9110000133514404},{"id":"https://openalex.org/keywords/apoe-deficient-mice","display_name":"ApoE-deficient mice","score":0.9089999794960022},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8650000095367432},{"id":"https://openalex.org/keywords/th1-polarization","display_name":"Th1 polarization","score":0.7429999709129333},{"id":"https://openalex.org/keywords/th2-polarization","display_name":"Th2 polarization","score":0.953000009059906},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.9879999756813049},{"id":"https://openalex.org/keywords/immunomodulatory-therapy","display_name":"immunomodulatory therapy","score":0.38199999928474426}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7327924370765686},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6455115079879761},{"id":"https://openalex.org/C57089818","wikidata":"https://www.wikidata.org/wiki/Q424728","display_name":"Apolipoprotein E","level":3,"score":0.5812304019927979},{"id":"https://openalex.org/C2780931953","wikidata":"https://www.wikidata.org/wiki/Q9371","display_name":"Spleen","level":2,"score":0.5463916659355164},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5461300015449524},{"id":"https://openalex.org/C2780404050","wikidata":"https://www.wikidata.org/wiki/Q416331","display_name":"Pentoxifylline","level":2,"score":0.5288577675819397},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.5131929516792297},{"id":"https://openalex.org/C2781156865","wikidata":"https://www.wikidata.org/wiki/Q827023","display_name":"Lesion","level":2,"score":0.4737361669540405},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.46562430262565613},{"id":"https://openalex.org/C2781136212","wikidata":"https://www.wikidata.org/wiki/Q632518","display_name":"T helper cell","level":4,"score":0.4398234784603119},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.4377889931201935},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.41947585344314575},{"id":"https://openalex.org/C2776682551","wikidata":"https://www.wikidata.org/wiki/Q21072584","display_name":"Macrophage polarization","level":4,"score":0.4192933440208435},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4180847406387329},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.35950642824172974},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3374382555484772},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.23247870802879333},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22930070757865906},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.22464394569396973},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.158107191324234},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.15549024939537048},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.0954328179359436},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08107516169548035},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001057","descriptor_name":"Apolipoproteins E","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":true},{"descriptor_ui":"D001057","descriptor_name":"Apolipoproteins E","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001161","descriptor_name":"Arteriosclerosis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001161","descriptor_name":"Arteriosclerosis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002452","descriptor_name":"Cell Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002454","descriptor_name":"Cell Differentiation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002454","descriptor_name":"Cell Differentiation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010431","descriptor_name":"Pentoxifylline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010726","descriptor_name":"Phosphodiesterase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013154","descriptor_name":"Spleen","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D013154","descriptor_name":"Spleen","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013154","descriptor_name":"Spleen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013154","descriptor_name":"Spleen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016753","descriptor_name":"Interleukin-10","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018417","descriptor_name":"Th1 Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018417","descriptor_name":"Th1 Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018417","descriptor_name":"Th1 Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018418","descriptor_name":"Th2 Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1161/01.cir.104.2.197","doi":"https://doi.org/10.1161/01.cir.104.2.197","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.cir.104.2.197","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmid:11447086","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11447086","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.533.6231","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.533.6231","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://circ.ahajournals.org/content/104/2/197.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320320893","display_name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","ror":"https://ror.org/02vjkv261"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W20509213","https://openalex.org/W1510730676","https://openalex.org/W1548820511","https://openalex.org/W1575331985","https://openalex.org/W1645175399","https://openalex.org/W1942668068","https://openalex.org/W1975881881","https://openalex.org/W1988078235","https://openalex.org/W2000367276","https://openalex.org/W2003600964","https://openalex.org/W2016072047","https://openalex.org/W2016292097","https://openalex.org/W2031777305","https://openalex.org/W2034229904","https://openalex.org/W2062395730","https://openalex.org/W2065447230","https://openalex.org/W2072199622","https://openalex.org/W2079926187","https://openalex.org/W2090560337","https://openalex.org/W2092834104","https://openalex.org/W2108021901","https://openalex.org/W2120265067","https://openalex.org/W2120363949","https://openalex.org/W2120758187","https://openalex.org/W2131649847","https://openalex.org/W2141672711","https://openalex.org/W2145699341","https://openalex.org/W2152391417","https://openalex.org/W2159782604","https://openalex.org/W2170079782","https://openalex.org/W2170958741","https://openalex.org/W2407370417"],"related_works":["https://openalex.org/W2114749112","https://openalex.org/W2052617165","https://openalex.org/W2953097524","https://openalex.org/W1968350849","https://openalex.org/W2015700821","https://openalex.org/W2062054118","https://openalex.org/W818530723","https://openalex.org/W1990478798","https://openalex.org/W2103647983"],"abstract_inverted_index":{"BACKGROUND:":[0],"A":[1],"chronic":[2],"immune":[3,35,193],"response":[4,36,194],"involving":[5],"proinflammatory":[6],"T":[7,127,152,184],"helper":[8,185],"cell":[9],"1":[10],"(Th1)":[11],"lymphocyte":[12],"activation":[13,22],"occurs":[14],"in":[15],"the":[16,34,38,57,88,104,123,141,147,180,191,205],"atherosclerotic":[17,74,100],"lesion,":[18],"but":[19,145,162],"whether":[20],"this":[21,217],"is":[23,198],"protective":[24],"or":[25,61,67],"deleterious":[26,199],"remains":[27],"unclear.":[28],"Methods":[29],"and":[30,117,200],"Results--":[31],"We":[32],"modulated":[33],"of":[37,56,90,106,125,132,143,149,183,204],"atherosclerosis-prone":[39],"apolipoprotein":[40],"E-deficient":[41],"(apoE(-/-))":[42],"mouse.":[43],"Eight-week-old":[44],"apoE(-/-)":[45],"mice":[46,81,96,175],"were":[47,85],"treated":[48],"daily":[49],"with":[50,196],"pentoxifylline":[51],"(PTX),":[52],"a":[53,202,211],"known":[54],"inhibitor":[55],"Th1":[58,109,165,181,192,206],"differentiation":[59,207],"pathway,":[60],"PBS":[62],"(control)":[63],"for":[64],"4":[65],"weeks":[66],"12":[68],"weeks.":[69],"Twelve-week":[70],"PTX":[71,133,156,173],"treatment":[72],"reduced":[73,114],"lesion":[75,118],"size":[76,119],"by":[77,115,151,178],"60%":[78],"(P<0.01).":[79],"PTX-treated":[80],"developed":[82,97],"lesions":[83],"that":[84,155,190,201],"limited":[86],"to":[87,122,134,215],"degree":[89],"fatty":[91],"streaks.":[92],"In":[93,102,129],"contrast,":[94],"control":[95],"mature":[98],"fibrofatty":[99],"lesions.":[101],"parallel,":[103],"proportion":[105,124],"interferon":[107],"(IFN)-gamma-producing":[108],"splenic":[110],"lymphocytes":[111],"was":[112,120],"significantly":[113],"PTX,":[116],"correlated":[121],"IFN-gamma(+)":[126],"cells.":[128],"vitro":[130],"addition":[131],"cultured":[135],"spleen":[136],"cells":[137],"did":[138],"not":[139,158],"modify":[140],"production":[142,148,161],"IFN-gamma":[144,160],"increased":[146],"IL-10":[150],"cells,":[153],"indicating":[154],"does":[157],"suppress":[159],"rather":[163],"blocks":[164],"polarization":[166,182],"while":[167],"promoting":[168],"Th2":[169],"polarization.":[170],"CONCLUSIONS:":[171],"Thus,":[172],"protected":[174],"from":[176],"atherosclerosis":[177,197],"reducing":[179],"lymphocytes.":[186],"This":[187],"study":[188],"demonstrates":[189],"associated":[195],"modulation":[203],"pathway":[208],"may":[209],"provide":[210],"new":[212],"pharmacological":[213],"tool":[214],"treat":[216],"disease.":[218]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":17},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}